Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02163187

Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation

Randomized Crossover Study of the Efficacy of Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Rectal Cancer for Bowel Dysfunction Following Surgery for Rectal Cancers

Interventions Implantation of the InterStimTM MSK BFI questionnaires The EuroQOL5D questionnaires The Fecal incontinence Quality of Life Scale (FIQOL) questionnaires The Low Anterior Resection Score (LARS) questionnaires

Updated 7 times since 2017 Last updated: Jan 10, 2018 Started: Jun 10, 2014 Primary completion: Dec 19, 2016 Completion: Dec 19, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study permanently closed due to low accrual

Other terminated trials from Memorial Sloan Kettering Cancer Center

See all terminations from Memorial Sloan Kettering Cancer Center

Other Rectal Cancer trials with similar outcome

Browse all Rectal Cancer trials

A PHASE2/PHASE3 clinical study on Rectal Cancer and for Bowel Dysfunction Following Surgery for Rectal Cancers, this trial is terminated or withdrawn. The trial is conducted by Memorial Sloan Kettering Cancer Center and has accumulated 7 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2_PHASE3
Dec 2017 — Jun 2018 [monthly]

Terminated PHASE2_PHASE3

Status: Completed → Terminated

▶ Show 2 earlier versions

Feb 2017 — Dec 2017 [monthly]

Completed PHASE2_PHASE3

Status: Active Not Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE2_PHASE3

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States